These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 100048)

  • 1. [Evaluation of the sanative action of rifampicin on the meningococcal carrier state].
    Deviatkina NP; Demina AA; Orlova EV; Timina VP; Petrova IS
    Antibiotiki; 1978 Sep; 23(9):794-7. PubMed ID: 100048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 3. [Healthy meningococcal carriers in 1973 in Greece. Sensitivity of the isolated strains to minocycline, rifampicin and sulphadiazine (author's transl)].
    Vassiliadis P; Patéraki E; Kalapothaki V; Trichopoulos D; Constantinidis E; Papadakis J
    Zentralbl Bakteriol Orig A; 1975; 230(2):159-71. PubMed ID: 807053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin in meningococcal carriers.
    Visakorpi R
    Scand J Infect Dis Suppl; 1989; 60():108-11. PubMed ID: 2667102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meningococcal disease: are patients carriers of meningococci after treatment with antibiotics?].
    Weis NM; Lind I
    Ugeskr Laeger; 1990 May; 152(19):1362-5. PubMed ID: 2111593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 9. [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
    Ercis S; Köseoğlu O; Salmanzadeh-Ahrabi S; Ercis M; Akin L; Hasçelik C
    Mikrobiyol Bul; 2005 Oct; 39(4):411-20. PubMed ID: 16544542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
    Devine LF; Hannah JM; Hagerman CR; Rhode SL; Peckinpaugh RO
    Mil Med; 1973 Jan; 138(1):20-4. PubMed ID: 4630051
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    JAMA; 1970 Nov; 214(6):1055-9. PubMed ID: 4990906
    [No Abstract]   [Full Text] [Related]  

  • 12. Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis.
    Simmons G; Jones N; Calder L
    J Antimicrob Chemother; 2000 Jun; 45(6):909-11. PubMed ID: 10837450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
    Beam WE; Newberg NR; Devine LF
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibiotic sensitivity of meningococci isolated from patients and carriers].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):532-5. PubMed ID: 6431380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and experimental rifampicin passage through the hemato-encephalic barrier and its effectiveness in treating meningococcal infections].
    Ivanov KS; Verovaia AV; Dergunova GA; Duiunov VM; Popova NN
    Antibiotiki; 1981 May; 26(5):383-8. PubMed ID: 7259147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of rifampin on the carrier state of Neisseria meningitidis and drug-sensitivity test (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):371-2. PubMed ID: 6806022
    [No Abstract]   [Full Text] [Related]  

  • 18. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
    Cuevas LE; Kazembe P; Mughogho GK; Tillotson GS; Hart CA
    J Infect Dis; 1995 Mar; 171(3):728-31. PubMed ID: 7876629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers.
    Devine LF; Pollard RB; Krumpe PE; Hoy ES; Mammen RE; Miller CH; Peckinpaugh RO
    Am J Epidemiol; 1973 Jun; 97(6):394-401. PubMed ID: 4197420
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of rifampicin in eradication of carrier state of Staphylococcus aureus in anterior nares with recurrent furunculosis.
    Mashhood AA; Shaikh ZI; Qureshi SM; Malik SM
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):396-9. PubMed ID: 16787615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.